Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Quality of life improved after COVID-19, but ongoing health support is needed.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Insulin resistance linked to obesity may increase COVID-19 severity.

Anabolic steroid users may face higher risk of severe COVID-19.

More clinical trials are needed to confirm if plant-based products can effectively treat COVID-19.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

The pandemic changed how often certain skin conditions were diagnosed.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Severe COVID-19 increases the risk of hair loss.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

COVID-19 and its vaccine can cause skin issues, but most are minor and resolve on their own.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.